Harris Health System's Ben Taub Hospital is the recipient of a newly created recognition by the American Heart Association/American Stroke Association’s Get With The Guidelines®- Stroke Gold Plus-Target: Stroke Honor Roll Elite Plus Award. The award means the hospital achieved high marks for response and care provided for acute ischemic strokes, the most common stroke—87 percent of all cases—in America.
Eighteen percent of drivers on academic and medical campuses use their cell phones while driving, according to researchers from The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
An experimental drug that attacks brain tumor tissue by crippling the cells' energy source called the mitochondria has passed early tests in animal models and human tissue cultures, say Houston Methodist scientists.
Harris Health System is now using sign language video technology to better communicate with its hearing-impaired and hard-of-hearing patients. Connecting patients with physicians and nurses in a timely and convenient manner is one of the driving forces behind the new portable iPad®-equipped wheeled carts (similar to rolling blood-pressure stands) that act as in-person translators of American Sign Language for patients and staff at a moment’s notice. The program has four such carts complete with speakers and audio enhancement capability at Harris Health’s Ben Taub, Quentin Mease and Lyndon B. Johnson hospitals.
A new clip helps older patients with mitral valve prolapse and who are not strong enough for open surgery.
Dr. Spencer Greene wants to make sure the standard treatment for copperhead snake bites, the most common venomous snake in greater Houston and southeast Texas, works, and if it doesn’t, he wants to stop its use. A national research is being coordinated at 18 healthcare sites across the country—Harris Health System's Ben Taub Hospital is one of five in Texas.
The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by researchers at The University of Texas MD Anderson Cancer Center.
Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Anderson Cancer Center, received the 2015 Paul Ehrlich and Ludwig Darmstaedter Prize Saturday in recognition of his work opening a completely new way to treat cancer.
The Children’s Learning Institute (CLI) at The University of Texas Health Science Center at Houston (UTHealth) and the Texas Education Agency (TEA) have launched a new, innovative online platform, known as CLI Engage. This online platform is now available at no cost to all Texas public school districts, charter schools and Head Start programs.
For the first time in the world, researchers at The University of Texas Health Science Center at Houston (UTHealth) were able to enroll patients at other hospitals into an acute stroke clinical trial.
Harris Health System has been named among the “Best 50” healthcare providers in the U.S. and Canada for its industry-leading efforts in supply chain management by the Global Healthcare Exchange (GHX), a worldwide healthcare technology company.
Armed with a microscope capable of zooming in on organisms measured in billionths of a meter, scientists report they are the first to observe one of the tiny molecular machines that bacteria use to infect host cells. Findings appear in the Proceedings of the National Academy of Sciences.
Scientists at The University of Texas MD Anderson Cancer Center have discovered new information about a key pathway known as Hippo, a metaphoric name referencing its link to tissue “overgrowth.” The Hippo pathway has been shown to regulate cell death and cell growth, thus playing a role in the development or prevention of tumors.
Scientists say they know how white adipose cells -- often called "bad fat" -- can be converted into "good," brown adipose in mice using little more than a synthetic stand-in for thyroid hormone.
Robin Garza knows trauma. She sees it on a daily basis as trauma services program manager for one of the busiest Level I trauma centers in the U.S.—Harris Health System’s Ben Taub Hospital. In fact, her advocacy to raise awareness about the dangers of trauma led her to develop Just Drive, a statewide campaign to discourage distracted driving, including texting and driving.
The Texas Department of State Health Services has reverified the Level III trauma center for Harris Health System’s Lyndon B. Johnson Hospital, a distinction the hospital has held since 1996.
Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide.
Belinda Reininger, Dr.P.H., M.P.H., associate professor in the Department of Health Promotion & Behavioral Sciences at The University of Texas Health Science Center at Houston (UTHealth), has been honored with the Faculty Award for Excellence in Academic Public Health Practice.
A surgical algorithm developed and implemented by ovarian cancer specialists at The University of Texas MD Anderson Cancer Center dramatically increases the frequency of complete removal of all visible tumor – a milestone strongly tied to improved survival.
Patrick Hwu, M.D., chair of Melanoma Medical Oncology and Sarcoma Medical Oncology at The University of Texas MD Anderson Cancer Center, has been named division head of Cancer Medicine effective March 4.
Rice University catcher, John Clay Reeves, felt pain in his groin after a collision at the plate with an opposing player. He thought he had pulled a muscle, but it turns out he was suffering from a common condition seen in teens and young adults known as hip impingement.
A clinical trial investigating the use of a physician-monitored app to help first-time minority stroke patients become healthier has begun at The University of Texas Health Science Center at Houston (UTHealth).
Powerful drugs known as BRAF-inhibitors have been crucial for melanoma patients, saving lives through their ability to turn off the BRAF protein’s power to spur cancer cell growth.
Cesar A. Arias, M.D., Ph.D., associate professor in the Division of Infectious Diseases at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been elected to the American Society for Clinical Investigation (ASCI). It is an honor society comprised of more than 3,000 physician scientists.
By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston Methodist researchers say they can destroy blood clots 100 to 1,000 times faster than a commonly used clot-busting technique.
The University of Texas MD Anderson Cancer Center has received more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas (CPRIT).
Tumors require blood to emerge and spread. That is why scientists at The University of Texas MD Anderson Cancer Center believe that targeting blood vessel cells known as pericytes may offer a potential new therapeutic approach when combined with vascular growth factors responsible for cell death.
Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings nationwide, to promote behavior that will lower children’s lifelong risk of developing cancer.
Ron DePinho, M.D., president of The University of Texas MD Anderson Cancer Center, will be inducted as a new fellow of the American Association for Cancer Research (AACR) Academy.
Increased awareness of the importance of digestive health has quickly turned into a multi-million dollar industry. According to Global Industry Analysts, the probiotics market is expected to exceed $29 billion by 2015 and expected to rise 7 percent a year over the next five years.
The University of Texas MD Anderson Cancer Center returns March 7 to Sarasota, Fla., for the institution’s annual Making Cancer History® seminar at the Hyatt Regency Sarasota, 1000 Blvd. of the Arts.
Raghu Kalluri, M.D., Ph.D., chair, cancer biology at The University of Texas MD Anderson Cancer Center, has received a notable scientific award from a top German university.
In a pivotal Phase III study led by researchers at The University of Texas MD Anderson Cancer Center, the oral anti-angiogenic therapy lenvatinib has shown dramatic improvement in progression-free survival in patients with advanced radioiodine-refractory thyroid cancer.
Houston experienced its hottest summer on record in 2011, resulting in 278 excess emergency department visits per day during the August heat wave, according to research from The University of Texas Health Science Center at Houston (UTHealth) published recently in Environmental Health.
When skyscrapers go up, contractors rely on an infrastructure of steel beams and braces. Some cancers grow the same way, using a biological matrix from which the tumor can thrive and spread.
Scottish author Robert Louis Stevenson tapped into primal fears when he penned “Dr. Jekyll and Mr. Hyde,” a 19th century novel about a sinister physician, raising the question, “Can evil and good exist in the same person?”
Researchers at The University of Texas MD Anderson Cancer Center have identified eight highly specific physical and cognitive signs associated with imminent death in cancer patients. The findings, published in the journal Cancer, could offer clinicians the ability to better communicate with patients and families. They may also guide both the medical team and caregivers on complex decision making, such as discontinuation of tests and therapy, plans for hospital discharge and hospice referral.
An international clinical trial led by faculty at The University of Texas Health Science Center at Houston (UTHealth) supports the use of a blood transfusion protocol developed by military doctors. Findings appear in JAMA.
The University of Texas MD Anderson Cancer Center and AstraZeneca today announced a multiyear strategic research collaboration to conduct multiple, parallel clinical and clinically related studies in ovarian and other gynecologic cancers with the aim of improving patient outcomes.
Lorraine Frazier, Ph.D., R.N., F.A.A.N., has been named dean of The University of Texas Health Science Center at Houston (UTHealth) School of Nursing, effective Feb. 2.
A new collaboration between Bayer and The University of Texas MD Anderson Cancer Center will go straight to the patients to learn how certain investigational new drugs affect them. The project will involve the use of questionnaires to assess how a drug may impact a patient’s disease-related symptoms.
The University of Texas MD Anderson Cancer Center was presented the People’s Republic of China International Science and Technology Cooperation Award at a ceremony held Jan. 9 at Beijing’s Great Hall of the People.
An exhaustive hereditary analysis of a large Louisiana family with vision issues has uncovered a new gene tied to an incurable eye disorder called retinitis pigmentosa, according to an examination led by scientists at The University of Texas Health Science Center at Houston (UTHealth). It is a family of eye diseases that affects more than 200,000 in the United States and millions worldwide
With the dawn of the modern era of new chemotherapeutic and biologic agents available for managing their disease, patients with metastatic colorectal cancer are undergoing less surgery for the removal of their primary tumors, according to research from The University of Texas MD Anderson Cancer Center.
Intrexon Corporation, a leader in synthetic biology and its oncology partner, ZIOPHARM Oncology, today announced a broad exclusive licensing agreement with The University of Texas MD Anderson Cancer Center, including an exclusive sublicensing agreement through MD Anderson for intellectual property developed at the University of Minnesota for the development of non-viral adoptive cellular cancer immunotherapies.
The University of Texas MD Anderson Cancer Center and Amgen have announced a research collaborative agreement focusing on Amgen’s bispecific T cell engager (BiTE®) antibody constructs, an immunotherapy that serves as a “bridge” between T cells and cancer cells.
Two professors in the School of Public Health at The University of Texas Health Science Center at Houston (UTHealth) – Stephen Daiger, Ph.D., and Robert Hardy, Ph.D. – have been elected to the rank of Fellow in the American Association for the Advancement of Science (AAAS) for their efforts to prevent blindness.
A significant portion of state and federal prisoners are not receiving treatment for mental health conditions, according to research by The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
Oncoceutics Inc. and The University of Texas MD Anderson Cancer Center today announced the initiation of a strategic alliance and research collaboration agreement for the clinical development of ONC201, a novel anti-cancer drug.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right